Concepedia

A Phase II Trial of Daily Perillyl Alcohol in Patients with Advanced Ovarian Cancer: Eastern Cooperative Oncology Group Study E2E96

Howard H. Bailey, Donna E. Levy, Linda S. Harris, Julian C. Schink, Francine Foss, Peter A. Beatty, Scott Wadler

Gynecologic Oncology · 2002 · 76 citations · 10 references

DOI

Concepts

References

10

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

, , +10

Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.

J.T. Thigpen, John A. Blessing, Harrison Ball et al. · Journal of Clinical Oncology · 1994 · 389 citations

, , +17

Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study.

G.J. Creemers, Giorgio Bolis, M. Gore et al. · Journal of Clinical Oncology · 1996 · 386 citations

, , +17

Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites.

P. L. Crowell, Ruey-Yi Chang, Zhonghai Ren et al. · Journal of Biological Chemistry · 1991 · 268 citations · Full text

, , +11

Phase I clinical trial of perillyl alcohol administered daily.

Gregory H. Ripple, Michael N. Gould, James A. Stewart et al. · PubMed · 1998 · 116 citations

, , +14